Jonas Banefelt and Johan Mesterton co-authored the poster “Impact of PSA Doubling Time Calculation Method on Estimate of Association with Bone Metastases in a Cohort of Prostate Cancer Patients Treated with Androgen Deprivation Therapy”, which was presented at the 29th […]
The paper “Predictors of Clinical Metastases and Survival among Non-Metastatic Prostate Cancer Patients Treated with Androgen-Deprivation Therapy in Sweden”, co-authored by Jonas Banefelt and Johan Mesterton, was presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Fredrik Borgström, Gylfi Olafsson and Oskar Ström have authored an article in Osteoporosis International that analyses the impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management based on the FREE trial.
Link
Linda Karlsson attended the conference ”Registry-based research in Sweden – past, present and future” organised by the Unit of Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet. For more information regarding register-based research in Sweden see […]
Anders Gustavsson has co-authored an article on treatment patterns in neuropathic pain, published in Pain Medicine.
Pubmed link
Fredrik Borgström has co-authored an article in Value in Health that compared the cost-effectiveness of biologic treatments for rheumatoid arthritis based on clinical trial data versus data from the Swedish RA registry. Pubmed link
The first publication based on the International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) co-authored by Fredrik Borgström and Oskar Ström has been published in Osteoporosis International. The ICUROS prospectively collects data on costs and quality of life […]
The first Quantify Research Newsletter of 2013 has been published.
Quantify Research are pleased to have welcomed several new talented employees in recent months. Introductions to all our employees can be found in the Biographies section.
Oskar Ström published a retrospective study in Osteoporosis International analyzing the impact of automatic generic substitution on treatment persistence in 36,433 patients. Between 2006 and 2009, the proportion of prescriptions constituting a generic substitution increased from 10.8% to 45.2%, and […]